Kevan R. Thompson
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Synthesis of β-Lactam Compounds, Protease and Inhibitor Mechanisms, Peptidase Inhibition and Analysis, Asymmetric Synthesis and Catalysis, Metal complexes synthesis and properties
Most-Cited Works
- → Mechanistic Aspects of Chiral Discrimination on Modified Cellulose(1997)212 cited
- → Cephalosporin antibiotics can be modified to inhibit human leukocyte elastase(1986)166 cited
- → Inhibition of human leukocyte elastase. 2. Inhibition by substituted cephalosporin esters and amides(1990)52 cited
- → Chemical, biochemical, pharmacokinetic, and biological properties of L-680,833: a potent, orally active monocyclic beta-lactam inhibitor of human polymorphonuclear leukocyte elastase.(1993)34 cited
- → Preparation and Cyclization of Aryloxyacetaldehyde Acetals; A General Synthesis of 2,3-Unsubstituted Benzofurans(1989)29 cited
- → Prevention of human leukocyte elastase-mediated lung damage by 3-alkyl-4-azetidinones(1991)28 cited
- → Mechanistic Aspects of Chiral Discrimination on an Amylose Tris(3,5-dimethylphenyl)carbamate(2002)24 cited
- → The effect of N-acyl substituents on the stability of monocyclic β-lactam inhibitors of human leukocyte elastase(1992)17 cited
- → Inhibition of human leukocyte elastase. 6. Inhibition by 6-substituted penicillin esters.(1993)14 cited
- → Inhibition of human leukocyte elastase. 7. Inhibition by 6-substituted penicillin amides.(1993)10 cited